I'll research Morgan Stanley (MS) before writing the preview. Let me start by gathering recent filings, transcripts, and news.Let me read Morgan Stanley's most recent (Q1 2026) earnings release and transcript, and pull prior-year Q2 results plus stock price data.Let me get the prior-year Q2 (2025Q2) results for year-over-year comparison and search for consensus estimates.Let me pull the Q1 2026 earnings call transcript for management's outlook/pipeline commentary, and get more granular consensus estimates.I have what I need. Here's the earnings preview.
Morgan Stanley walks into this print riding one of the best capital-markets tapes in years — and carrying elevated expectations to match. The stock closed $227.71 on July 14, up ~4% on the day alongside a broad bank rally, and is up roughly 25% year-to-date (from ~$182 at the start of January). At those levels MS trades at roughly 4.4x Q1 tangible book value ($51.58) and ~3.4x book value ($66.18) — a premium multiple that leaves little room for disappointment.
The peer reads this week set a very high bar: - JPMorgan posted record revenue, with investment banking fees up ~30% and equity trading up ~86% YoY. - Goldman Sachs broke its own trading-revenue record and the stock jumped ~7.5% on the day — the purest read-through for MS's institutional franchise. - Wells Fargo beat handily on lower provisions and expense control.
The key risk isn't the fundamentals — it's positioning. Per UBS's Erika Najarian, the buy side has crowded into a "long Goldman / short Morgan Stanley" trade, betting on GS as the cleaner capital-markets expression versus MS's loftier price-to-tangible-book multiple. Her warning: MS needs to both beat consensus meaningfully AND deliver an encouraging pipeline outlook to satisfy a "super crowded" setup. A good-but-not-great quarter could still sell off.
| Metric | Q2 2026 Consensus | Q2 2025 Actual | YoY |
|---|---|---|---|
| EPS | ~$2.77 (range $2.73–$2.81) | $2.13 | ~+30% |
| Net revenues | ~$19.3B | $16.8B | ~+15% |
| IB revenue | ~$2.09B | $1.54B | ~+36% |
Note the sequential optics: Q2 will likely step down from Q1's record ($20.6B revenue, $3.43 EPS, 27.1% ROTCE), largely because Q1 benefits from a seasonally low tax rate (share-award conversions drove a 19.6% Q1 rate; management guides full-year to 22–23%). Don't confuse normal seasonality with deceleration — the YoY comparison is what matters.
Institutional Securities — the swing factor. Q1 was a record $10.7B (Equity a record $5.1B, FICC a post-crisis record $3.4B, IB $2.1B with advisory +74% YoY). Given GS's and JPM's blowout trading and IB numbers, expectations for MS's markets businesses are high. The variable investors care most about is investment banking momentum. On the Q1 call, CFO Sharon Yeshaya described IB pipelines as "steady," and CEO Ted Pick pointed to a building sponsor pipeline: ~$1T+ of PE dry powder, 1,500+ private companies worth $1B+, and rising two-track (sale vs. IPO) bake-offs. Watch for confirmation that the ECM/advisory pipeline is converting, not just building. Also watch Asia — it drove ~45% of Q1's sequential revenue improvement (prime brokerage strength).
Wealth Management — quality of NNA under the microscope. Q1 delivered a record $8.5B in revenue, a 30.4% pre-tax margin, and a standout $118B of net new assets with $54B of fee-based flows. Two things to watch: 1. Net new assets — Najarian flagged that wealth flows are seasonally pressured by April tax payments; management said on the Q1 call that taxes were tracking "as expected" and that securities-based lending started Q2 strong. A NNA figure in the ~$50–60B+ range (vs. $59B in Q2'25) would reassure. 2. NII — management guided to a modest sequential increase in Q2 vs. Q1's $2.17B, supported by lending growth (balances $186B) and sweep deposits. With the Fed on hold at 3.50–3.75% and June CPI cooling to 3.5%, the rate backdrop is roughly stable.
Investment Management — steady, watch flows. Q1 was ~$1.5B with $3.3B of long-term net flows (Parametric + fixed income). Not a needle-mover, but flow trends and carried-interest accruals are worth a glance.
The fundamental backdrop is about as good as it gets for MS — strong trading, reviving IB, and a wealth franchise compounding client assets toward $10T+. The debate is entirely about the bar and the positioning. With peers having already printed records and MS at ~4.4x tangible book in a crowded long-GS/short-MS trade, the market likely needs: (1) a clear beat on EPS and revenue, (2) markets revenue that keeps pace with GS/JPM, (3) evidence the IB/ECM pipeline is converting, and (4) resilient wealth NNA despite tax-season seasonality. Anything short of "beat + confident outlook" risks an unwind of the crowded trade even on decent numbers. Conversely, a clean beat with an upbeat pipeline could force the shorts to cover.
Preview based on MS's Q1 2026 results and call, Q2 2025 comparables, peer prints (JPM/GS/WFC), current Street estimates, and the July 2026 macro/rate backdrop. Not investment advice.